PTC Therapeutics | PTCT - Ebitda





Ebitda Veränderung Datum
Acadia Pharmaceuticals USD 20.31M 15.44M 2025-12
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Amgen USD 5.14B 775M 2025-12
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Biogen USD 649.7M 76.5M 2026-03
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Cytokinetics USD -169.32M 19.48M 2026-03
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
Esperion Therapeutics USD -9.93M 24.99M 2025-09
Gilead Sciences USD 3.02B 1.01B 2025-12
Incyte USD 367.97M 46.53M 2026-03
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Novartis USD 5.3B 530M 2026-03
Pfizer USD 5.99B 5.23B 2026-03
PTC Therapeutics USD -70.99M 91.62M 2025-12
Puma Biotechnology USD 729K 11.36M 2024-06
Roche Holding CHF 12.68B 2.36B 2024-06
Sarepta Therapeutics USD -252.2M 84.16M 2025-12
TG Therapeutics USD 51.69M 19M 2025-12
Ultragenyx Pharmaceutical USD -99.43M 57.35M 2025-12
Vertex Pharmaceuticals USD 1.19B 195.3M 2026-03
Xencor USD -51.05M 55.28M 2025-12